Correlation Between Acrivon Therapeutics, and Opthea
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Opthea at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Opthea into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Opthea, you can compare the effects of market volatilities on Acrivon Therapeutics, and Opthea and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Opthea. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Opthea.
Diversification Opportunities for Acrivon Therapeutics, and Opthea
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Acrivon and Opthea is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Opthea in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opthea and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Opthea. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opthea has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Opthea go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Opthea
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to generate 1.46 times more return on investment than Opthea. However, Acrivon Therapeutics, is 1.46 times more volatile than Opthea. It trades about 0.01 of its potential returns per unit of risk. Opthea is currently generating about 0.0 per unit of risk. If you would invest 1,262 in Acrivon Therapeutics, Common on August 28, 2024 and sell it today you would lose (546.00) from holding Acrivon Therapeutics, Common or give up 43.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 97.37% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Opthea
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Opthea |
Acrivon Therapeutics, and Opthea Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Opthea
The main advantage of trading using opposite Acrivon Therapeutics, and Opthea positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Opthea can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opthea will offset losses from the drop in Opthea's long position.| Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. HCW Biologics | Acrivon Therapeutics, vs. Scpharmaceuticals | Acrivon Therapeutics, vs. Milestone Pharmaceuticals |
| Opthea vs. Molecular Partners AG | Opthea vs. MediciNova | Opthea vs. Anebulo Pharmaceuticals | Opthea vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |